INTERNATIONAL PATENT: GUARDANT HEALTH, INC. FILES APPLICATION FOR "METHYLATION BIOMARKERS FOR OSIMERTINIB TREATMENT MANAGEMENT"

GENEVA, March 11 -- GUARDANT HEALTH, INC. (3100 Hanover StreetPalo Alto, California 94304) filed a patent application (PCT/US2025/043587) for "METHYLATION BIOMARKERS FOR OSIMERTINIB TREATMENT MANAGEMENT" on Aug 26, 2025. With publication no. WO/2026/050287, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HARDIN, Aaron Isaac (3100 Hanover StreetPalo Alto, California 94304)

Abstract: Described herein are methods and compositions related to methylation-based determination and characterization of subjects afflicted with vari...